Detection of Anaplasma phagocytophilum in an inflammatory pericardial effusion of a dog.

An 11-year-old female spayed German Wirehaired Pointer with a 1-week history of lethargy, hyporexia, diarrhea, and coughing presented with pericardial effusion causing cardiac tamponade. An echocardiogram revealed no structural cause for pericardial effusion. The pericardial effusion was an exudate with mixed macrophagic and neutrophilic inflammation. Morulae occasionally were found within neutrophils. The pericardial fluid and blood were qPCR and cPCR positive for Anaplasma phagocytophilum (NC State University, Vector-borne Disease Diagnostic Laboratory, Raleigh, NC). The dog's blood was negative by ELISA (Vetscan Flex4 Rapid Test, Zoetis, Parsippany, NJ) for A. phagocytophilum antibodies at initial presentation and subsequently positive (SNAP4DxPlus, IDEXX, Westbrook, ME) 7 days later. After pericardiocentesis and administration of doxycycline (5 mg/kg PO q12h for 14 days), a repeat echocardiogram performed 1 month later showed no recurrence of pericardial effusion.

Respiratory distress in small animals: Pathophysiology and clinical approach.

BACKGROUND: Respiratory distress is a common reason for animals to present to the emergency room. An understanding of respiratory physiology is helpful to facilitate accurate localization of the patient's source of respiratory distress. This knowledge will aid implementation of more appropriate therapies. PHYSIOLOGY/PATHOPHYSIOLOGY SUMMARY: Respiratory distress can occur secondary to lesions at any location of the respiratory system. Diseases affecting different portions of the respiratory track (eg, upper airway, lower airways, parenchymal, or the pleural space) lead to distinguishing clinical signs as the patient's respiratory physiology is affected differently. CLINICAL IMPORTANCE: Respiratory distress can be life-threatening if it is not recognized and addressed in a timely matter. Prompt recognition of unique clinical signs may aid the clinician's ability to localize the disease process and implement targeted therapies. KEY POINTS: Diseases affecting different portions of the respiratory track (eg, upper airway, lower airways, parenchymal, or the pleural space) lead to distinguishing clinical signs as the patient's respiratory physiology is affected differently. Recognition of respiratory patterns allows clinicians to correlate clinical signs to the most likely affected region of the respiratory tract. Ideally, alveolar gas (ventilation) and blood flow (perfusion) are equally matched. However, even a normal lung does not have ideal ventilation/perfusion (V/Q) matching. There are a variety of conditions that lead to decreased lung compliance, from pathology of the pulmonary parenchyma (eg, pulmonary edema, alveolar infiltrates such as pneumonia or contusions, or pulmonary fibrosis), pleural space disease (eg, pneumothorax or pleural effusion), abdominal distension, or the inability to expand the rib cage (eg, pain, thoracic wall injury, constricting thoracic bandages). The five classic causes of hypoxemia include low FiO2 , diffusion impairment, hypoventilation, shunt, and V/Q mismatch. Being prepared to rapidly induce anesthesia and intubate dyspneic animals with upper airway obstruction may be required alleviate the risk of respiratory arrest.

Performing an upper airway examination in dogs.

BACKGROUND: Increased airway resistance due to upper airway obstruction is a common cause of respiratory distress. An upper airway exam is an inexpensive and quick diagnostic procedure that can serve to localize a disease process, confirm a definitive diagnosis, and offer therapeutic benefits. DESCRIPTION: The upper airway examination consists of an external evaluation of the head and neck as well as a sedated examination of the oral cavity, the pharyngeal cavity, larynx, and nasal passages. SUMMARY: An upper airway examination should be performed in patients with increased inspiratory effort or increased upper respiratory noise (eg, stertor or stridor). A complete, sedated upper airway examination should be considered for patients with clinical signs of upper airway disease for which a cause is not obvious from the physical examination. KEY POINTS: Indications for an upper airway examination include sneezing, nasal discharge or epistaxis, reduced or absent nasal airflow, change in phonation, inspiratory difficulty, and audible respiratory sounds. Upper airway examination helps localize pathological processes and allows the clinician to confirm or exclude several differential diagnoses. Pre-oxygenation of the patient for 3-5 minutes prior to sedation will help increase the amount of time available before hypoxemia occurs, should complications arise. Upon completion of the upper airway examination, it is important to monitor the patient carefully and ensure a safe recovery. Careful planning to ensure the availability of necessary equipment and preparation of the team to react during and after the airway examination will minimize the risks of examination to patients with upper airway disease.

Growth of adenocarcinoma from canine pleural fluid on aerobic bacterial culture.

We report a case of canine adenocarcinoma with multi-organ metastasis in which colonies of adenocarcinoma cells grew upon aerobic bacterial culture of pleural effusion. Stained agar colonies were highly similar to rare suspicious cells seen on cytologic examination of the pleural effusion, as well as rare cells seen on cytologic examination of pancreatic and gastric wall fine-needle aspirates. Cells from colonies growing on agar media were mildly immunoreactive for cytokeratin. Histologic examination of tissues obtained at autopsy revealed pancreatic adenocarcinoma with vascular invasion and nodal, gastric, pulmonary, and pleural metastasis.

Acute respiratory distress syndrome and septic shock in a cat with disseminated toxoplasmosis.

OBJECTIVE: To describe acute respiratory distress syndrome (ARDS) and septic shock in a cat with disseminated toxoplasmosis. CASE SUMMARY: A 2-year-old neutered male domestic shorthair cat was presented for acute respiratory distress. At the time of presentation it had been receiving cyclosporine for treatment of eosinophilic dermatitis. Thoracic radiographs revealed severe mixed nodular interstitial and alveolar patterns. An endotracheal wash was performed, which confirmed a diagnosis of pulmonary toxoplasmosis. Despite initial treatment with oxygen supplementation and intravenous clindamycin, the cat developed refractory hypoxemia and hypotension requiring mechanical ventilation and vasopressor support within 24 hours of hospital admission. Cardiac arrest occurred 56 hours after admission. Necropsy was performed and histopathology revealed protozoal organisms disseminated throughout the heart, lungs, liver, and brain. NEW OR UNIQUE INFORMATION PROVIDED: The clinical and necropsy findings presented here are consistent with ARDS secondary to disseminated toxoplasmosis in a cat. This is the first detailed report of ARDS in a cat. Toxoplasma titer testing and antimicrobial prophylaxis should be considered in cats prior to immunosuppressive treatment with cyclosporine.

Comparison of the efficacy of small and large-bore thoracostomy tubes for pleural space evacuation in canine cadavers.

OBJECTIVE: To determine if there is a difference in the amounts of air (A), low-viscosity fluid (LV), or high-viscosity fluid (HV) that can be aspirated from the pleural cavity of canine cadavers using small-bore (SB) or large-bore (LB) thoracostomy tubes. DESIGN: Prospective experimental ex vivo study. SETTING: University teaching hospital. ANIMALS: Thirty-six canine cadavers. INTERVENTIONS: Each cadaver was randomly assigned to 1 of 6 groups (SB-A, LB-A, SB-LV, LB-LV, SB-HV, LB-HV). In each cadaver bilateral thoracostomy tubes (either SB or LB) were placed and 20 mL/kg of air, LV fluid, or HV fluid was instilled via 1 thoracostomy tube. Both tubes were aspirated and the volume aspirated was recorded and analyzed as a percentage of instilled air or fluid volume. The procedure was repeated on the contralateral hemithorax. MEASUREMENTS AND MAIN RESULTS: There was no significant difference in air or fluid recovery when SB and LB groups were compared. Median (range) air recovery volumes in the SB-A and LB-A groups were 101.5% (94.4-115.8%) and 102.8% (94.1-107.8%), respectively (P = 0.898). Recovery of LV fluid was 93.5% (79.2-99.0%) for SB-LV and 85.8% (77.1-101.8%) for LB-LV cadavers (P = 0.305) and recovery percentages of HV fluid were 92.6% (86.1-96.2%) and 91.4% (74.2-96.4%) for SB-HV and LB-HV groups, respectively (P > 0.999). There was no significant difference between SB and LB groups when all substances were combined (94.1% [79.2-115.8%] and 93.5% [74.2-107.8%], respectively, P = 0.557). CONCLUSIONS: SB and LB thoracostomy tubes demonstrated similar efficacy in removing known amounts of air, LV fluid, and HV fluid from the pleural space of canine cadavers. Further study is necessary to determine if SB and LB thoracostomy tubes demonstrate similar efficacy in clinical veterinary patients.

Evaluation of the effects of time, temperature, and specimen storage on in vitro lactate concentrations in healthy dogs.

BACKGROUND: Lactate concentrations increase significantly under certain storage conditions, except for when glycolysis-arresting agents are used. Evaluation of time and storage conditions on heparinized whole blood lactate concentrations without glycolysis-arresting agents have not been evaluated in dogs. OBJECTIVES: The purpose of the study was to determine the effects of preanalytic storage conditions on the in vitro concentration of lactate in heparinized canine venous blood specimens. METHODS: In this prospective study, blood collected from 30 healthy dogs was aliquoted and stored under different conditions: anaerobic refrigerated (3°C), aerobic refrigerated, anaerobic room temperature (RT), and aerobic RT. Whole blood lactate was analyzed at 15-25, 30-40, 60-70, and 120-130 minutes from time 0 (T0) under all storage conditions. Percent increases from the T0 specimen were calculated. RESULTS: There were significantly increased lactate concentrations at all time points within the anaerobic refrigerated specimens compared to T0, and in the anaerobic RT specimens after 15-25 minutes. The aerobic refrigerated specimens did not have significant changes in lactate when compared to anaerobic refrigerated specimens, while the aerobic RT specimens had significant increases at all time points. Anaerobically refrigerated specimens stored < 40 minutes and aerobically refrigerated specimens stored < 25 minutes had in vitro lactate increases of < 20%. CONCLUSIONS: Results support analyzing lactate specimens immediately. If lactate analysis is delayed, anaerobic refrigerated specimens should be analyzed within 40 minutes, and aerobic refrigerated specimens should be analyzed within 25 minutes. Room temperature specimens stored either aerobically or anaerobically should be avoided as lactate concentrations may be falsely increased.

Retrospective comparison of costs between medical and surgical treatment of canine pyothorax.

This study compared costs of treating dogs with pyothorax medically versus surgically. Medical records from the University of Wisconsin School of Veterinary Medicine were searched for cases of pyothorax that underwent either medical or surgical treatment. Patients undergoing surgery were subdivided into early (ES; < 48 h) and late (LS; > 48 h) surgery groups. Costs and length of stay were compared between treatment groups. Treatment costs were adjusted for inflation. Nineteen dogs were included in analysis; 7 in the medical group (MG), 5 in the ES group, and 7 in the LS group. Total costs were significantly lower in the MG than in the LS group. Total costs were less for the MG than the ES group, and for ES than LS, but the differences did not achieve significance. Preoperative costs were higher in the LS than the ES group. We conclude that surgery for canine pyothorax is less costly if pursued earlier than later.

Comparaison rétrospective des coûts entre le traitement médical et chirurgical d'un pyothorax canin. Cette étude a comparé les coûts de traiter les chiens souffrant d'un pyothorax par voie médicale par opposition à une voie chirurgicale. Une recherche a été effectuée dans les dossiers médicaux du College of Veterinary Medicine, University of Wisconsin pour trouver des cas de pyothorax où les animaux avaient subi soit un traitement médical ou chirurgical. Les patients subissant une chirurgie ont été subdivisés en des groupes de chirurgie précoce (ES; < 48 h) et tardive (LS; > 48 h). Les coûts et la durée du séjour ont été comparés entre les groupes de traitement. Les coûts de traitement ont été ajustés pour l'inflation. Dix-neuf chiens étaient inclus dans l'analyse; sept dans le groupe médical (MG), cinq dans le groupe ES et sept dans le groupe LS. Les coûts totaux étaient significativement inférieurs dans le MG par rapport au groupe LS. Les coûts totaux étaient inférieurs pour le groupe MG par rapport au groupe ES et pour le groupe ES par rapport au groupe LS, mais les différences n'étaient pas significatives. Les coûts préopératoires étaient supérieurs dans le groupe LS par rapport au groupe ES. Nous tirons la conclusion que le coût de la chirurgie pour le pyothorax canin est inférieur si la chirurgie est réalisée tôt.(Traduit par Isabelle Vallières).

Aortic tear and dissection related to connective tissues abnormalities resembling Marfan syndrome in a Great Dane.

Aortic tears and acute aortic dissection are rarely reported in dogs. This report describes a case of aortic dissection and probable sinus of Valsalva rupture in a young Great Dane with associated histopathologic findings suggestive of a connective tissue abnormality.

A case of necrolytic migratory erythema managed for 24 months with intravenous amino acid and lipid infusions.

A 9-year-old castrated male Shetland sheepdog was diagnosed with necrolytic migratory erythema and hepatocutaneous syndrome. Necrolytic migratory erythema was treated with intermittent intravenous amino acids as needed to control cutaneous lesions. The addition of lipid infusions extended the treatment interval. The patient had a favorable response for 24 months.

Cas d'érythème migratoire nécrolytique géré pendant 24 mois à l'aide d'infusions intraveineuses d'amino-acides et de lipides. Un chien berger Shetland mâle castré âgé de 9 ans a été diagnostiqué avec un érythème migratoire nécrolytique et un syndrome hépatocutané. L'érythème migratoire nécrolytique a été traité par des amino-acides intraveineux intermittents au besoin pour contrôler les lésions cutanées. L'ajout d'infusions de lipides a prolongé l'intervalle de traitement. Le patient a manifesté une réponse favorable pendant 24 mois.(Traduit par Isabelle Vallières).

Endoscopic polypectomy using endocautery in three dogs and one cat.

Endoscopic polypectomy has long been employed in humans with either gastric or colonic polyps. Despite the frequency of use in humans, reports in veterinary medicine remain scarce. The medical records of three dogs and one cat were reviewed. Two animals that were presented with hematochezia underwent colonoscopic polypectomy and were clinically normal 22 months and 6 months postpolypectomy. One animal that was presented with chronic vomiting underwent gastric polypectomy and was clinically normal 21 months postpolypectomy. One animal with an incidentally discovered gastric polyp underwent polypectomy without complication. Endoscopic polypectomy may be a viable alternative to surgery in veterinary patients with gastric or colonic polyps.

Hypoxemia: a quick reference.

The article describes the calculation of the alveolar-arterial gas gradient and its clinical application in determining the cause of hypoxemia. It also outlines the analysis of arterial blood gases and the clinical approach toward diagnosis and treatment of respiratory disease.

Metabolic acid-base disorders in the critical care unit.

The recognition and management of acid-base disorders is a commonplace activity in the critical care unit, and the role of weak and strong acids in the genesis of metabolic acid-base disorders is reviewed. The clinical approach to patients with metabolic alkalosis and metabolic acidosis is discussed in this article.

Advances in respiratory therapy.

Effective respiratory therapy depends on obtaining a definitive diagnosis and following established recommendations for treatment. Unfortunately, many respiratory conditions are idiopathic in origin or are attributable to nonspecific inflammation. In some situations, disorders are controlled rather than cured. Recent advances in pulmonary therapeutics include the use of new agents to treat common diseases and application of local delivery of drugs to enhance drug effect and minimize side effects.

Association of expiratory airway dysfunction with marked obesity in healthy adult dogs.

OBJECTIVE: To evaluate the effects of obesity on pulmonary function in healthy adult dogs. ANIMALS: 36 Retrievers without cardiopulmonary disease. PROCEDURES: Dogs were assigned to 1 of 3 groups on the basis of body condition score (1 through 9): nonobese (score, 4.5 to 5.5), moderately obese (score, 6.0 to 6.5), and markedly obese (score, 7.0 to 9.0). Pulmonary function tests performed in conscious dogs included spirometry and measurement of inspiratory and expiratory airway resistance (R(aw)) and specific R(aw) (sR(aw)) during normal breathing and during hyperpnea via head-out whole-body plethysmography. Functional residual capacity (FRC; measured by use of helium dilution), diffusion capacity of lungs for carbon monoxide (DLCO), and arterial blood gas variables (PaO(2), PaCO(2), and alveolar-arterial gradient) were assessed. RESULTS: During normal breathing, body condition score did not influence airway function, DLCO, or arterial blood gas variables. During hyperpnea, expiratory sR(aw) was significantly greater in markedly obese dogs than nonobese dogs and R(aw) was significantly greater in markedly obese dogs, compared with nonobese and moderately obese dogs. Although not significantly different, markedly obese dogs had a somewhat lower FRC, compared with other dogs. CONCLUSIONS AND CLINICAL RELEVANCE: In dogs, obesity appeared to cause airflow limitation during the expiratory phase of breathing, but this was only evident during hyperpnea. This suggests that flow limitation is dynamic and likely occurs in the distal (rather than proximal) portions of the airways. Further studies are warranted to localize the flow-limited segment and understand whether obesity is linked to exercise intolerance via airway dysfunction in dogs.

Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs.

Pulmonary arterial hypertension (PH) is a pathologic condition in dogs characterized by abnormally high pressures in the pulmonary circulation and has been associated with a poor outcome. Sildenafil is a type V phosphodiesterase inhibitor that produces nitric oxide mediated vasodilatation. Sildenafil treatment decreases pulmonary arterial pressure and pulmonary vascular resistance in people with PH. The purpose of this study was to describe the clinical characteristics and outcome of dogs with PH treated with sildenafil. The cardiology database was searched for dogs with PH treated with sildenafil. PH was defined as systolic pulmonary arterial pressure (PAPs) > or = 25 mmHg at rest. Medical records were reviewed for the following information: signalment, duration and type of clinical signs before treatment, underlying disease, estimated or measured PAPs, dosage and dosing interval of sildenafil, and the effect of treatment on clinical signs and pulmonary arterial pressure and survival time. Thirteen affected dogs were identified. Clinical signs included collapse, syncope, respiratory distress, and cough. Duration of clinical signs before presentation ranged from 3 days to 5 months. An underlying cause was identified in 8 dogs. The median sildenafil dosage was 1.9 mg/kg. Ten dogs received concurrent medications. Median PAPs was 90 mmHg; 8 dogs were reevaluated after therapy, and the median decrease in PAPs was 16.5 mmHg. The median survival time of all dogs was 91 days. Sildenafil appeared to be well tolerated in dogs with PH and was associated with decreased PAPs and amelioration of clinical signs in most. Sildenafil represents a reasonable treatment option for dogs with pulmonary hypertension.